Ultima Genomics

Ultima Genomics

生物技术研究

Fremont,California 18,362 位关注者

Unleashing the power of genomics at scale

关于我们

Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.

网站
https://www.ultimagenomics.com
所属行业
生物技术研究
规模
201-500 人
总部
Fremont,California
类型
私人持股
创立
2016
领域
Sequencing、genomics、biotechnology、engineering、chemistry、molecular biology、computational biology、software和machine learning

地点

  • 主要

    4209 Technology Dr

    US,California,Fremont,94538

    获取路线

Ultima Genomics员工

动态

  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    Ultima shares your excitement for enabling more affordable sequencing for all 'NGS-hungry' applications. Congratulations University of Minnesota on being one of the first Certified Service Providers in the world. Let the #UG100 sequencing begin. #NGS #UG100 #WGS #SingleCell #metagnomics #cfDNA

    查看University of Minnesota Genomics Center的公司主页,图片

    249 位关注者

    Big news from the UMGC! We’re thrilled to be among the first academic sites in the world to install the UG 100 by Ultima Genomics. This breakthrough technology enables sequencing an entire human genome for $100 in raw sequencing cost, opening doors to more affordable and scalable genomics research. For researchers, the UG 100 will not only provide affordable whole-genome sequencing. It will also supercharge single-cell genomics, the analysis of circulating free DNA in cancer, deep metagenomics sequencing, and other NGS-hungry applications. Currently carrying out pilot runs and training on the device, we will roll out our UG 100 sequencing service on January 2, 2025. The UMGC is one of just three global Certified Service Providers for the new technology. Read more at: https://bit.ly/4fV4h2d

    The Ultima UG 100 arrives at UMN, ushering in massive-scale DNA sequencing with ultra-high throughput, ultra-low-cost, and ultra-high quality

    The Ultima UG 100 arrives at UMN, ushering in massive-scale DNA sequencing with ultra-high throughput, ultra-low-cost, and ultra-high quality

    genomics.umn.edu

  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    We had an incredible turnout at our #AMPath24 workshop ‘Bridging the gaps towards implementing molecular residual disease in clinical practice – a collaborative view across the healthcare ecosystem’. The audience engagement was inquisitive and the panel discussion was rich in perspective. Many thanks to BLOODPAC for their partnership and much appreciation to Lauren C. Leiman for moderating and the esteemed panel of experts from academic and pharma including: Christina Lockwood, PhD (University of Washington), Jennifer Dickey, PhD (Labcorp), Kelli Bramlett (Quest Diagnostics), Krupa Paranjpe, Pharm.D (Sanofi Genzyme), and Ramin Dowlati, PhD (J&J). Clinical labs are adopting Ultima for the opportunity to develop new and transform existing assays that can enable more breadth, depth and with better economics. We developed our sequencing architecture to specifically meet the needs of large-scale applications by providing our customers with extremely low limits of detection at high throughput and at low-cost. Our?unique #ppmSeq technology provides customers with a path that enables part-per-million SNV accuracy for applications like #liquidbiopsy and #MRD that require lower limits of detection with more data and at lower cost. #WGS #UG100 ?

    • 该图片无替代文字
  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    Ultima couldn't be more thrilled to have Macrogen Inc. as our first Certified Service Provider partner. Our high-throughput, cost-effective sequencing is now even more accessible to the world. #Sequencing #NGS #UG100

    查看Macrogen Inc.的公司主页,图片

    5,980 位关注者

    We are excited to announce that ???? has been selected as the first global member of Ultima Genomics’ Certified Service Provider program! ?? ? Through a comprehensive evaluation process, Macrogen has been recognized for its excellence in delivering best-in-class #UG100? sequencing services. ? At Macrogen, we are dedicated to advancing global genomic research by offering cutting-edge solutions and leveraging our state-of-the-art genomic analysis infrastructure. ? We look forward to empowering researchers around the globe and driving the future of genomics forward! ???? #Genomics #sequencing #Macrogen #UltimaGenomics

    • 该图片无替代文字
  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    Ultima Genomics is honored to be named the 'Overall Genomics Company of the Year' in the Genomics & CGT category by BioTech Breakthrough, an organization recognizing leaders in life sciences and biotechnology globally. This award demonstrates our commitment to innovation and significant contributions to genomics, setting new industry benchmarks and fostering future scientific breakthroughs. Our groundbreaking #UG100 is at the heart of this achievement. By enabling high-throughput sequencing at substantially reduced costs, we're not only making the $100 genome a reality but also unleashing the power of genomics and utility of genomic research worldwide. Thank you to BioTech Breakthrough for this prestigious recognition and to our team whose relentless innovation continues to make a profound impact. Full list of winners: https://lnkd.in/gYXC6PQ5 #UltimaGenomics #BioTechBreakthrough #Genomics #Innovation #Healthcare #Sequencing #NGS

    2024 Winners - BioTech Breakthrough Awards

    2024 Winners - BioTech Breakthrough Awards

    https://biotechbreakthroughawards.com

  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    ??Final Reminder: Register now for our upcoming webinar this week! "Complete E2E Workflow for Germline WGS Variant Detection Using Fabric Genomics and Ultima Genomics." Gain insights into the latest advancements in #sequencing technology and #bioinformatics tools to enhance your germline WGS analysis workflows, in particular: 1. Explore Secondary Analysis Pipelines Discover the secondary analysis pipelines available for UG 100 sequencing data and how they streamline variant detection workflows. 2. Calling CNV/SV and Variants in Challenging Regions Learn how to accurately call copy number variants (CNV), structural variants (SV), and detect variants in segmental duplication regions using UG 100 data. 3. Seamless Integration of Fabric Analysis Pipeline Understand how to integrate the Fabric analysis pipeline effortlessly with UG 100 sequencing data for a comprehensive end-to-end workflow. This webinar is ideal for bioinformaticians, clinical researchers, and scientists involved in WGS data analysis who seek to improve their analysis pipelines and gain a deeper understanding of variant detection in challenging regions. ? We look forward to seeing you there! ? Date: Tuesday, 19th November 2024 Time: 10am PST, 12pm CST, 1pm EST Register here> https://ow.ly/9YbP50TYpLM Date: Wednesday, 20th November 2024 Time: 3pm GMT, 4pm CET Register here> https://ow.ly/1RBP50TYpLK Date: Thursday, 21st November 2024 Time: 2pm AEDT, 12pm JST, 4pm NZDT Register here> https://ow.ly/IGe450TYpLL #WGS #UG100 #AMPath24

    • 该图片无替代文字
  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    ?Reminder: Ultima Genomics will be exhibiting at the Association for Molecular Pathology (#AMPath24) annual meeting in Vancouver, CAN next week! We will be hosting a Fireside Chat together with BLOODPAC, a consortium whose mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer. The panel will represent a collaborative view across the healthcare ecosystem and will be compromised of leading global organizations with an interest in implementing Minimal Residual Disease in clinical practice. Moderator: Lauren C. Leiman (BLOODPAC) Panelists: Kelli Bramlett (Quest Diagnostics) Jennifer Dickey (Personal Genome Diagnostics, Labcorp Oncology) Christina Lockwood (University of Washington - School of Medicine) Krupa Paranjpe (Sanofi) Ramin Dowlati (Johnson & Johnson) ?And do stop by booth 1521 to meet the team! #WGS #NGS #MRD #LiquidBiopsies #UG100

  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    We are excited for Inocras Inc. to be presenting their new MRD product, MRDVision, leveraging Ultima's ppmSeq technology and UG 100 at next week's #AMPath2024 meeting.

    查看Inocras Inc.的公司主页,图片

    2,586 位关注者

    We're getting ready for the AMP 2024 Annual Meeting- stop by our booth (#1430) to learn about our MRDVision product! Don't miss the chance to hear our CMO Dr. Erin Connolly-Strong, PhD and CTO Dr. Sangmoon Lee, MD, PhD as they present on our new revolutionary MRD product, MRDVision, which achieves a parts-per-million (ppm) level sensitivity through our advanced cancer WGS platform and Ultima's ppmSeq technology. RSVP today! https://lnkd.in/gnWpZK33 #AMP2024

    • 该图片无替代文字
  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    Privileged to have Lauren C. Leiman be the moderator at our Fireside Chat next week at #AMPath2024. Join us for a lively conversation with a group of selected experts from pharmaceutical, academia, reference laboratories and consortium groups. We will provide a collaborative view of the ecosystem on the challenges and opportunities to bring MRD to clinical practice and clinical trial management. https://lnkd.in/gDFNRf7i

    查看BLOODPAC的公司主页,图片

    2,771 位关注者

    Reminder! Our Executive Director, Lauren C. Leiman, will be moderating an important panel discussion at the Association for Molecular Pathology (AMP) 2024 Annual Meeting in Vancouver, BC. Join Us: Date: November 20, 2024 Time: 12:00–12:50 PM (PST) Panel discussion: "Bringing MRD Testing to Clinical Practice to Improve Patient Outcomes"

    • 该图片无替代文字
  • 查看Ultima Genomics的公司主页,图片

    18,362 位关注者

    ??Reminder: Register now for our upcoming webinar next week! "Complete E2E Workflow for Germline WGS Variant Detection Using Fabric Genomics and Ultima Genomics." Gain insights into the latest advancements in #sequencing technology and #bioinformatics tools to enhance your germline WGS analysis workflows, in particular: 1. Explore Secondary Analysis Pipelines Discover the secondary analysis pipelines available for UG 100 sequencing data and how they streamline variant detection workflows. 2. Calling CNV/SV and Variants in Challenging Regions Learn how to accurately call copy number variants (CNV), structural variants (SV), and detect variants in segmental duplication regions using UG 100 data. 3. Seamless Integration of Fabric Analysis Pipeline Understand how to integrate the Fabric analysis pipeline effortlessly with UG 100 sequencing data for a comprehensive end-to-end workflow. This webinar is ideal for bioinformaticians, clinical researchers, and scientists involved in WGS data analysis who seek to improve their analysis pipelines and gain a deeper understanding of variant detection in challenging regions. ? We look forward to seeing you there! ? Date: Tuesday, 19th November 2024 Time: 10am PST, 12pm CST, 1pm EST Register here> https://ow.ly/9YbP50TYpLM Date: Wednesday, 20th November 2024 Time: 3pm GMT, 4pm CET Register here> https://ow.ly/1RBP50TYpLK Date: Thursday, 21st November 2024 Time: 2pm AEDT, 12pm JST, 4pm NZDT Register here> https://ow.ly/IGe450TYpLL #WGS #UG100 #AMPath24

    • 该图片无替代文字

相似主页

融资

Ultima Genomics 共 1 轮

上一轮

未知

US$600,000,000.00

Crunchbase 上查看更多信息